SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 4,405 shares at $9.59 ($42K) on 2017-12-26, disclosed to the SEC on 2017-12-28.
Scheduled sale ($42k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.59 | 1,602 | $15K | 36.5% |
| 2 | $9.54 | 2,803 | $27K | 63.5% |
| Total | $9.56 avg | 4,405 | $42K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |